Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -201.48%-51.05M | ---- | -68.98%50.3M | ---- | -34.74%162.16M | ---- | -3.33%248.48M | ---- | ---- |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -145.14%-15.08M | ---- | 181.46%33.41M | ---- | -20.36%-41.01M | ---- | -12.80%-34.07M | ---- | ---- |
| Impairment and provisions: | ---- | 77.51%98.98M | ---- | -33.18%55.76M | ---- | 498.18%83.45M | ---- | 5.51%13.95M | ---- | ---- |
| -Other impairments and provisions | ---- | 73.94%64.18M | ---- | --36.9M | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | 413.60%59.64M | ---- | 80.17%-19.02M | ---- | -340.59%-95.9M | ---- | 25.56%-21.77M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 79.82%-22.11K | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 79.82%-22.11K | ---- | ---- |
| Depreciation and amortization: | ---- | 10.40%60.92M | ---- | 31.20%55.18M | ---- | 54.26%42.06M | ---- | 10.85%27.26M | ---- | ---- |
| -Amortization of intangible assets | ---- | 1.89%3.58M | ---- | 1.19%3.52M | ---- | 31.45%3.48M | ---- | 19.66%2.64M | ---- | ---- |
| -Other depreciation and amortization | ---- | 200.00%183.5K | ---- | --61.17K | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial expense | ---- | -3.56%18.55M | ---- | -7.98%19.23M | ---- | 42.91%20.9M | ---- | -4.95%14.63M | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -293.64%-104.03M | ---- | -148.53%-26.43M | ---- | 176.41%54.46M | ---- | -31.46%-71.27M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | -197.81%-82.71M | ---- | 125.25%84.57M | ---- | -112.30%-334.87M | ---- | -411.88%-157.73M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | 248.97%56.31M | ---- | -47.30%-37.8M | ---- | -122.09%-25.66M | ---- | 216.13%116.16M | ---- | ---- |
| Special items of business | ---- | -9.36%-23.6M | ---- | -265.18%-21.58M | ---- | 56,574.97%13.07M | ---- | -99.00%23.05K | ---- | ---- |
| Adjustment items of business operations | -6.51%23.31M | -80.71%41.52M | -84.76%24.93M | 260.10%215.21M | 371.10%163.57M | -199.12%-134.42M | -169.83%-60.34M | -7.76%135.61M | ---- | 2,341.25%86.4M |
| Net cash from operations | -6.51%23.31M | -90.74%17.92M | -84.76%24.93M | 259.56%193.63M | 371.10%163.57M | -189.47%-121.35M | -169.83%-60.34M | -9.16%135.63M | 41.98%186.26M | 2,341.25%86.4M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -13.89%11.01M | 75.38%13.1M | 91.57%12.79M | 26.38%7.47M | --6.68M | -42.37%5.91M | ---- | 42.94%10.26M | ---- | ---- |
| Sale of fixed assets | ---- | 256.23%282.99K | 215.19%249K | --79.44K | --79K | ---- | ---- | -77.86%59K | ---- | -90.16%25K |
| Purchase of fixed assets | 44.59%-30.45M | 10.61%-84.62M | -12.31%-54.96M | 15.25%-94.67M | 40.39%-48.94M | 30.45%-111.7M | -149.63%-82.1M | -10.70%-160.62M | ---- | 45.56%-32.89M |
| Recovery of cash from investments | ---- | 6.41%58.78M | -82.59%9.68M | 455.22%55.24M | --55.6M | -5.34%9.95M | ---- | 442.11%10.51M | ---- | --7.51M |
| Cash on investment | ---- | ---38.31M | ---9.8M | ---- | ---- | 54.41%-5.48M | 34.19%-5.48M | 80.47%-12.01M | ---- | ---8.32M |
| Net cash from investment operations | 53.76%-19.44M | -59.26%-50.77M | -413.37%-42.04M | 68.54%-31.88M | 115.32%13.41M | 33.26%-101.32M | -160.07%-87.58M | 23.03%-151.8M | 30.52%-106.85M | 36.45%-33.68M |
| Net cash before financing | 122.65%3.87M | -120.31%-32.85M | -109.66%-17.1M | 172.64%161.75M | 219.65%176.98M | -1,277.35%-222.67M | -380.53%-147.91M | 66.25%-16.17M | ---- | 192.76%52.73M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 25.68%288.55M | 52.35%551.59M | 142.97%229.6M | -27.97%362.05M | -65.00%94.5M | 38.20%502.64M | 40.10%270M | 52.61%363.71M | ---- | 3,754.52%192.73M |
| Refund | -5.67%-170.95M | -1.95%-454.55M | 22.24%-161.77M | -143.35%-445.85M | -198.42%-208.04M | 52.84%-183.21M | 37.60%-69.71M | -109.63%-388.5M | ---- | -272.42%-111.73M |
| Dividends paid - financing | -2.55%-8.92M | 57.56%-27.01M | 13.23%-8.7M | 10.04%-63.63M | 42.01%-10.03M | -345.79%-70.73M | -114.11%-17.29M | 76.99%-15.87M | ---- | 29.46%-8.07M |
| Other items of the financing business | -393.14%-3.45M | -3,554.03%-25.58M | -104.73%-700K | 95.34%-700K | 711.82%14.8M | -11.09%-15.01M | 95.36%-2.42M | 83.42%-13.51M | ---- | -380.34%-52.13M |
| Net cash from financing operations | 80.09%105.23M | 130.01%44.46M | 153.73%58.43M | -163.39%-148.13M | -160.23%-108.77M | 531.44%233.69M | 768.38%180.58M | 42.86%-54.16M | -885.07%-101.55M | 143.96%20.8M |
| Effect of rate | 67.53%-126K | -21.77%-697.89K | -63.03%-388K | -1,089.67%-573.14K | -112.50%-238K | -88.10%57.91K | -23.08%-112K | 127.27%486.79K | 82.33%-107.7K | -113.68%-91K |
| Net Cash | 163.97%109.11M | -14.72%11.61M | -39.41%41.33M | 23.53%13.61M | 108.82%68.22M | 115.67%11.02M | -55.57%32.67M | 50.71%-70.33M | 32.73%-22.13M | 170.60%73.52M |
| Begining period cash | 12.12%100.97M | 16.93%90.06M | 16.93%90.06M | 16.80%77.02M | 16.80%77.02M | -51.44%65.94M | -51.44%65.94M | -51.55%135.78M | ---- | -51.55%135.79M |
| Cash at the end | 60.26%209.95M | 12.12%100.97M | -9.65%131.01M | 16.93%90.06M | 47.21%145M | 16.80%77.02M | -52.92%98.5M | -51.44%65.94M | ---- | 18.34%209.21M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.